Kate Duvall is Corporate Controller at Fate Therapeutics and is responsible for overseeing accounting operations and technical accounting, financial reporting, and SOX compliance. Prior to joining Fate, Ms. Duvall served as an auditor at Ernst & Young LLP for clients in the life sciences, health care, and retail industries. Ms. Duvall is a Certified Public Accountant in the State of California. She holds a bachelor’s degree in accounting from the University of San Diego.